Remepy
Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps
$36MSeries A
Role not disclosedQC
Qumra Capital
Activity from announced rounds
Activity in this selectioncaterina-fake-61c38908
- Rounds participated in
- 6
- Confirmed lead rounds
- — 6 roles undisclosed
- New companies
- 6 First participation on record · 0 follow-on
- Funding in participating rounds
- $346M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
6 in this selectionQuantHealth
AI-driven platform that simulates clinical trials to predict outcomes before patient enrollment
$45MSeries B
Role not disclosedZenity
AI security and governance platform purpose-built for enterprise AI agents
$125MSeries C
Role not disclosedTytoCare
AI-first clinical enablement company and developer of remote physical examination technology featuring FDA-cleared medical devices
>$25MGrowth
Role not disclosedQodo
Building AI agents for code review, testing, and governance
$70MSeries B
Role not disclosedDatarails
Provides AI-native financial platform for CFO's Office across FP&A, cash management, month-end cl...
$70MSeries C
Role not disclosed